{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T20:33:50Z","timestamp":1775680430421,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001674","name":"Leducq Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/04090-0"],"award-info":[{"award-number":["2015\/04090-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/09398-8"],"award-info":[{"award-number":["2017\/09398-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2021\/05827-7"],"award-info":[{"award-number":["2021\/05827-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/24419-4"],"award-info":[{"award-number":["2018\/24419-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/08996-4"],"award-info":[{"award-number":["2019\/08996-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2021\/03066-9"],"award-info":[{"award-number":["2021\/03066-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejphar.2024.177027","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T06:20:06Z","timestamp":1727850006000},"page":"177027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Small-molecule mediated MuRF1 inhibition protects from doxorubicin-induced cardiac atrophy and contractile dysfunction"],"prefix":"10.1016","volume":"984","author":[{"given":"Paula K.N.","family":"Alves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7955-7324","authenticated-orcid":false,"given":"Volker","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anselmo S.","family":"Moriscot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9009-210X","authenticated-orcid":false,"given":"Siegfried","family":"Labeit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.177027_bib1","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/jcsm.12968","article-title":"Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility","volume":"13","author":"Adams","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ejphar.2024.177027_bib2","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/jcsm.12448","article-title":"Small\u2010molecule\u2010mediated chemical knock\u2010down of MuRF1\/MuRF2 and attenuation of diaphragm dysfunction in chronic heart failure","volume":"10","author":"Adams","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ejphar.2024.177027_bib3","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.3390\/cells9102272","article-title":"Small-molecule chemical knockdown of MuRF1 in melanoma bearing mice attenuates tumor cachexia associated myopathy","volume":"9","author":"Adams","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2024.177027_bib4","doi-asserted-by":"crossref","first-page":"7198","DOI":"10.3390\/ijms23137198","article-title":"miR-29c increases protein synthesis in skeletal muscle independently of AKT\/mTOR","volume":"23","author":"Alves","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ejphar.2024.177027_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.39116","article-title":"Chemotherapy-related toxic effects and quality of life and physical functioning in older patients","volume":"6","author":"Baltussen","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ejphar.2024.177027_bib6","doi-asserted-by":"crossref","first-page":"F1545","DOI":"10.1152\/ajprenal.00686.2011","article-title":"Protein abundance of urea transporters and aquaporin 2 change differently in nephrotic pair-fed vs. non-pair-fed rats","volume":"302","author":"Bou Matar","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2024.177027_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054738","article-title":"Erlotinib preserves renal function and prevents salt retention in doxorubicin treated nephrotic rats","volume":"8","author":"Bou Matar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.177027_bib8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/jcsm.12233","article-title":"Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia","volume":"8","author":"Bowen","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ejphar.2024.177027_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12032-023-01954-6","article-title":"How to reduce its adverse effects while maintaining the potency?","volume":"40","author":"Brianna","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ejphar.2024.177027_bib10","article-title":"Cardiomyocyte atrophy, an underestimated contributor in doxorubicin-induced cardiotoxicity","volume":"9","author":"Chen","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ejphar.2024.177027_bib11","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jcmg.2018.05.012","article-title":"Anthracycline therapy is associated with cardiomyocyte atrophy and preclinical manifestations of heart disease","volume":"11","author":"de Souza","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.ejphar.2024.177027_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10585-021-10106-x","article-title":"Cardiooncology\u2014dealing with modern drug treatment, long-term complications, and cancer survivorship","volume":"38","author":"de Wall","year":"2021","journal-title":"Clin. Exp. Metastasis"},{"issue":"11","key":"10.1016\/j.ejphar.2024.177027_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258878","article-title":"Proliferation, apoptosis and their regulatory protein expression in colorectal adenomas and serrated lesions","volume":"16","author":"Figueiredo","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.177027_bib14","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1152\/japplphysiol.00776.2009","article-title":"Doxorubicin acts through tumor necrosis factor receptor subtype 1 to cause dysfunction of murine skeletal muscle","volume":"107","author":"Gilliam","year":"2009","journal-title":"J. Appl. Physiol."},{"issue":"12","key":"10.1016\/j.ejphar.2024.177027_bib15","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1074\/mcp.RA118.000652","article-title":"Doxorubicin-induced DNA damage causes extensive ubiquitination of ribosomal proteins associated with a decrease in protein translation","volume":"17","author":"Halim","year":"2018","journal-title":"Mol Cell Proteomics MCP"},{"key":"10.1016\/j.ejphar.2024.177027_bib16","article-title":"Doxorubicin-induced skeletal muscle atrophy: elucidating the underlying molecular pathways","volume":"229","author":"Hiensch","year":"2022","journal-title":"Acta Physiol."},{"key":"10.1016\/j.ejphar.2024.177027_bib17","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.apsb.2019.03.003","article-title":"Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPK \u03b1\/UCP2 pathway","volume":"9","author":"Hu","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2024.177027_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.124","article-title":"Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin-induced cardiotoxicity","volume":"10","author":"Hu","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ejphar.2024.177027_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101747","article-title":"Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP\/PKA\/SIRT1 pathway","volume":"37","author":"Hu","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2024.177027_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710146","article-title":"Dapagliflozin mitigates doxorubicin-caused myocardium damage by regulating AKT-mediated oxidative stress, cardiac remodeling, and inflammation","volume":"23","author":"Hsieh","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177027_bib21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jcsm.12265","article-title":"Prevention of chemotherapy-induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscle","volume":"9","author":"Hulmi","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"12","key":"10.1016\/j.ejphar.2024.177027_bib22","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/jpp\/rgac063","article-title":"Doxorubicin-induced cardiotoxicity: causative factors and possible interventions","volume":"74","author":"Jones","year":"2022","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177027_bib23","doi-asserted-by":"crossref","first-page":"46663","DOI":"10.18632\/oncotarget.16944","article-title":"Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity","volume":"8","author":"Koleini","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2024.177027_bib24","first-page":"424","article-title":"Doxorubicin-induced cardiomyopathy 17 years after chemotherapy","volume":"39","author":"Kumar","year":"2012","journal-title":"Tex. Heart Inst. J."},{"key":"10.1016\/j.ejphar.2024.177027_bib25","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.3390\/ijms22042225","article-title":"Regulation of glucose metabolism by MuRF1 and treatment of myopathy in diabetic mice with small molecules targeting MuRF1","volume":"22","author":"Labeit","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177027_bib26","doi-asserted-by":"crossref","first-page":"H2541","DOI":"10.1152\/ajpheart.01052.2008","article-title":"A therapeutic dose of doxorubicin activates ubiquitin-proteasome system-mediated proteolysis by acting on both the ubiquitination apparatus and proteasome","volume":"295","author":"Liu","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2024.177027_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103109","article-title":"Redox homeostasis in cardiac fibrosis: focus on metal ion metabolism","volume":"71","author":"Liu","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2024.177027_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13073-019-0703-1","article-title":"Molecular profiling for precision cancer therapies","volume":"12","author":"Malone","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.ejphar.2024.177027_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.847012","article-title":"Cardiotoxicity of anticancer drugs: molecular mechanisms and strategies for cardioprotection","volume":"9","author":"Morelli","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177027_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/srep32695","article-title":"Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes","volume":"6","author":"Nissinen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.177027_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180571","article-title":"Early transcriptional alteration of histone deacetylases in a murine model of doxorubicin-induced cardiomyopathy","volume":"12","author":"Piotrowska","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.177027_bib32","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.3390\/ijms24043637","article-title":"Small-molecule inhibition of MuRF1 prevents early disuse-induced diaphragmatic dysfunction and atrophy","volume":"24","author":"Ribeiro","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177027_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.00050","article-title":"Human pluripotent stem cell-derived cardiomyocytes for assessment of anticancer drug-induced cardiotoxicity","volume":"7","author":"Schwach","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ejphar.2024.177027_bib34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12032-022-01677-0","article-title":"Innovation in cancer therapeutics and regulatory perspectives","volume":"39","author":"Sharma","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ejphar.2024.177027_bib35","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1113\/jphysiol.2014.270101","article-title":"Resveratrol protects against doxorubicin-induced cardiotoxicity in aged hearts through the SIRT1-USP7 axis","volume":"593","author":"Sin","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2024.177027_bib36","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.radcr.2022.12.048","article-title":"Delayed doxorubicin induced cardiomyopathy in a breast cancer patient: a case report","volume":"18","author":"Song","year":"2023","journal-title":"Radiol Case Rep"},{"key":"10.1016\/j.ejphar.2024.177027_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110566","article-title":"AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium\/CaMKII\/MuRF-1 axis","volume":"381","author":"Syamprasad","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177027_bib38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177027_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005234","article-title":"Doxorubicin exposure causes subacute cardiac atrophy dependent on the striated muscle\u2013specific ubiquitin ligase MuRF1","volume":"12","author":"Willis","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ejphar.2024.177027_bib40","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.emboj.7601952","article-title":"Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2","volume":"27","author":"Witt","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2024.177027_bib41","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1074\/jbc.RA119.011571","article-title":"Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2\u2013mediated activation of forkhead box O1","volume":"295","author":"Xia","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2024.177027_bib42","first-page":"1968","article-title":"Transgenic overexpression of active HDAC4 in the heart attenuates cardiac function and exacerbates remodeling in infarcted myocardium","volume":"125","author":"Zhang","year":"2018","journal-title":"J Appl Physiol Bethesda Md 1985"},{"key":"10.1016\/j.ejphar.2024.177027_bib43","doi-asserted-by":"crossref","first-page":"556","DOI":"10.7150\/ijbs.29907","article-title":"Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity","volume":"15","author":"Zhang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2024.177027_bib44","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41418-019-0372-z","article-title":"FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT","volume":"27","author":"Zhang","year":"2020","journal-title":"Death Differ"},{"key":"10.1016\/j.ejphar.2024.177027_bib45","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12916-022-02287-3","article-title":"Targeted therapies for cancer","volume":"20","author":"Zhou","year":"2022","journal-title":"BMC Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T01:02:19Z","timestamp":1734570139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924007179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":45,"alternative-id":["S0014299924007179"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177027","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small-molecule mediated MuRF1 inhibition protects from doxorubicin-induced cardiac atrophy and contractile dysfunction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177027"}}